Extrahepatic autoimmunity in autoimmune liver disease

Area of Science:

• Immunology
• Hepatology
• Rheumatology

Background:

• Autoimmune liver diseases (AILDs) encompass autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis.
• A significant proportion of AILD patients (approximately 33%) present with co-occurring extrahepatic autoimmune diseases.
• These extrahepatic conditions can affect various organ systems, including rheumatological, endocrinological, gastrointestinal, pulmonary, and dermatological systems.

Purpose of the Study:

• To review the clinical manifestations of extrahepatic autoimmunity in patients with AILDs.
• To elucidate the pathophysiological mechanisms underlying the association between AILDs and extrahepatic autoimmune conditions.
• To highlight the concept of a continuous spectrum of autoimmunity involving both liver and extrahepatic tissues.

Main Methods:

• Literature review focusing on clinical and pathophysiological aspects.
• Synthesis of data on autoimmune liver diseases and associated extrahepatic autoimmune conditions.
• Analysis of immune responses targeting cholangiocytes and extrahepatic tissues.

Main Results:

• AILDs frequently present with associated autoimmune conditions in other organs.
• Immune responses, both innate and adaptive, play a crucial role in the pathogenesis.
• Extrahepatic autoimmunity can be viewed as a continuum extending from liver autoimmunity.

Conclusions:

• Extrahepatic autoimmunity is a common and integral feature of autoimmune liver disease.
• Understanding this spectrum is crucial for comprehensive patient management.
• Further research into shared pathophysiological pathways is warranted.